Loading…
Loading…
EQUITY / NASDAQ · XNCM
Bluejay Diagnostics Inc.
01 / RESEARCH
8 financial reports are available for research.
Start research ↗0.8686 USD · 1.6025%
Observed: Sep 30, 2026, 11:59 PM · TickerLayer indicative price; may be delayed
Powered by TickerLayer
09/30/2026 · 0.8549 USD · Volume 394,386
251 actual observations · Latest bar: 2026-09-30 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2026 – 06/30/2026 · Units
| Metric | 2026 / Quarter 2 | 2025 / Quarter 2 | Change |
|---|---|---|---|
| Cash and cash equivalents | 9,598,916 USD | — | — |
| Net income | -2,324,013 USD | -1,956,604 USD | — |
| Operating profit | -2,349,124 USD | -1,985,361 USD | — |
| Total assets | 11,533,900 USD | — | — |
| Total equity | 9,414,840 USD | 5,290,231 USD | +77.97% |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 2ConsolidatedUnits · USD | 2026 / Quarter 2ConsolidatedUnits · USD | 2026 / Quarter 2ConsolidatedUnits · USD | 2025 / Quarter 2ConsolidatedUnits · USD | 2025 / Year endConsolidatedUnits · USD | 2025 / Quarter 3ConsolidatedUnits · USD | 2025 / Quarter 3ConsolidatedUnits · USD | 2025 / Quarter 2ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 9,598,916 USD | — | — | 5,164,875 USD | 5,164,875 USD | 3,082,268 USD | — | — |
| Net incomeIncome statement | -2,324,013 USD | -4,243,254 USD | -1,919,241 USD | — | -6,848,483 USD | -1,597,632 USD | -5,418,671 USD | -1,956,604 USD |
| Operating profitIncome statement | -2,349,124 USD | -4,287,955 USD | — | — | -6,952,972 USD | -1,616,947 USD | -5,491,225 USD | -1,985,361 USD |
| Total assetsBalance sheet | 11,533,900 USD | — | — | 7,119,237 USD | 7,119,237 USD | 4,890,258 USD | — | — |
| Total equityBalance sheet | 9,414,840 USD | — | 4,181,195 USD | 5,975,289 USD | 5,975,289 USD | 3,692,782 USD | — | 5,290,231 USD |
| Total liabilitiesBalance sheet | 2,119,060 USD | — | — | 1,143,948 USD | 1,143,948 USD | 1,197,476 USD | — | — |
| Capital expendituresCash flow statement | — | 161,762 USD | — | — | 173,735 USD | — | — | — |
| Financing cash flowCash flow statement | — | 7,680,684 USD | — | — | 7,090,240 USD | — | 3,379,028 USD | — |
| Investing cash flowCash flow statement | — | -158,087 USD | — | — | -173,735 USD | — | — | — |
| Operating cash flowCash flow statement | — | -3,088,556 USD | — | — | -6,053,575 USD | — | -4,598,705 USD | — |
| Report source | Open report ↗ Published: 08/12/2026 | Open report ↗ Published: 08/12/2026 | Open report ↗ Published: 08/12/2026 | Open report ↗ Published: 08/12/2026 | Open report ↗ Published: 03/06/2026 | Open report ↗ Published: 11/07/2025 | Open report ↗ Published: 11/07/2025 | Open report ↗ Published: 08/12/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.